MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:GNVR)

0.7928 UNCHANGED
Last Price Updated: 10:08 AM EDT, Mar 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.7928
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.7928
Today's Range 0.7928 - 0.7928
52wk Range 0.0140 - 2.000
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026
Via ACCESS Newswire
News headline image
Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions
Company’s proprietary peptide platform expands beyond agriculture into human recovery, performance, and wellness 
From Genvor Inc
Via GlobeNewswire

Performance

YTD
-39.0%
-39.0%
1 Month
+36.4%
+36.4%
3 Month
-47.1%
-47.1%
6 Month
-47.1%
-47.1%
1 Year
+198100.0%
+198100.0%

More News

Read More
News headline image
Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor to Participate in World Agri-Tech Innovation Summit in San Francisco
Via ACCESSWIRE
News headline image
Genvor to Attend BioSolutions Conference & Expo in Visalia, California
Via ACCESSWIRE
News headline image
Genvor Provides Fiscal First Quarter 2024 Corporate Update
Via ACCESSWIRE
News headline image
Genvor Appoints Veteran Agribusiness Leader Chad Pawlak as Chief Executive Officer
Via ACCESSWIRE
News headline image
Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference
From Genvor Inc
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for December 11th
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Genvor to Present at the Life Sciences Virtual Investor Forum December 11th
From Virtual Investor Conferences; Genvor, Inc.
Via GlobeNewswire
News headline image
Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
Via NewMediaWire
Topics Intellectual Property
News headline image
Genvor Inc. Partners With B2i Digital as Featured Company to Expand Investor Awareness
Via TheNewswire.com
Topics Intellectual Property
News headline image
Genvor Announces Issuance of New U.S. Patent for Corn with Antifungal Peptide
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor Restores Trading Status and Expands Global Collaborative Research Network
From Genvor Inc
Via GlobeNewswire
News headline image
Genvor to Unveil Latest Research on Patented Peptides for Aflatoxin Resistance in Corn at BioAgTech World Congress
Via ACCESSWIRE
News headline image
Genvor to Participate in BioAgTech World Congress in Raleigh, North Carolina
Via ACCESSWIRE

Frequently Asked Questions

Is GNVR publicly traded?
Yes, GNVR is publicly traded.
What exchange does GNVR trade on?
GNVR trades on the OTC Traded
What is the ticker symbol for GNVR?
The ticker symbol for GNVR is GNVR on the OTC Traded
What is the current price of GNVR?
The current price of GNVR is 0.7928
When was GNVR last traded?
The last trade of GNVR was at 03/26/26 10:08 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story